195
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

High Prevalence of Abnormal Carcinoembryonic Antigen in Diabetic Inpatients with Poor Glycemic Control

, &
Pages 2345-2352 | Published online: 04 Aug 2022

References

  • Kwon YJ, Lee HS, Shim JY, Lee YJ. Serum carcinoembryonic antigen is positively associated with leukocyte count in Korean adults. J Clin Lab Anal. 2018;32(3):e22291. doi:10.1002/jcla.22291
  • Bertola G, Balza G, Oriani A, et al. Elevated concentration of serum carcinoembryonic antigen in hypothyroidism. Recenti Prog Med. 2004;95(4):204–206.
  • Kaplan I, Bulut M, Atli A, et al. Serum levels of carcinoembryonic antigen (CEA) in patients with bipolar disorder. Acta Neuropsychiatr. 2015;27(3):177–181. doi:10.1017/neu.2015.5
  • Docci D, Turci F, Pistocchi E. High levels of carcinoembryonic antigen (CEA) in the serum of uremic patients under hemodialysis treatment. Quad Sclavo Diagn. 1984;20(4):435–439.
  • Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. doi:10.1016/j.diabres.2021.109119
  • Tsilidis KK, Kasimis JC, Lopez DS, et al. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ. 2015;350:g7607. doi:10.1136/bmj.g7607
  • Cheng Y-C, Li Y-H, Hsu C-Y, et al. Synergistic association of carcinoembryonic antigen and carbohydrate antigen 19-9 on the Risk of Abnormal Glucose Regulation. Diabetes Metab Syndr Obes. 2020;13:1933–1942. doi:10.2147/DMSO.S256223
  • Chung S, Lee Y, Roh EY. HbA1c showed a positive association with carcinoembryonic antigen (CEA) level in only diabetes, not prediabetic or normal individuals. J Clin Lab Anal. 2019;33(6):e22900. doi:10.1002/jcla.22900
  • Chen J, Tao F, Zhang B, et al. Elevated squamous cell carcinoma antigen, cytokeratin 19 fragment, and carcinoembryonic antigen levels in diabetic nephropathy. Int J Endocrinol. 2017;2017:5304391. doi:10.1155/2017/5304391
  • Liu X-Y. The high prevalence of short-term elevation of tumor markers due to hyperglycemia in diabetic patients. Diabetes Metab Syndr Obes. 2022;15:1113–1122. doi:10.2147/DMSO.S350599
  • Yu H, Li R, Zhang L, et al. Serum CA19-9 level associated with metabolic control and pancreatic beta cell function in diabetic patients. Exp Diabetes Res. 2012;2012:745189. doi:10.1155/2012/745189
  • Elimam H, Abdulla AM, Taha IM. Inflammatory markers and control of type 2 diabetes mellitus. Diabetes Metab Syndr. 2019;13(1):800–804. doi:10.1016/j.dsx.2018.11.061
  • Jeong S, Park MJ, Song W, et al. Current immunoassay methods and their applications to clinically used biomarkers of breast cancer. Clin Biochem. 2020;78:43–57. doi:10.1016/j.clinbiochem.2020.01.009
  • Bergman M, Abdul-Ghani M, DeFronzo RA, et al. Review of methods for detecting glycemic disorders. Diabetes Res Clin Pract. 2020;165:108233. doi:10.1016/j.diabres.2020.108233
  • Burchill MA, Finlon JM, Goldberg AR, et al. Oxidized low-density lipoprotein drives dysfunction of the liver lymphatic system. Cell Mol Gastroenterol Hepatol. 2021;11(2):573–595. doi:10.1016/j.jcmgh.2020.09.007
  • Dai B, Xu L, Jiankun X, et al. Synergistic effects of magnesium ions and simvastatin on attenuation of high-fat diet-induced bone loss. Bioact Mater. 2021;6(8):2511–2522. doi:10.1016/j.bioactmat.2021.01.027
  • Cai Z, Huang L, Chen Y, et al. CEA decline predicts tumor regression and prognosis in locally advanced rectal cancer patients with elevated baseline CEA. J Cancer. 2020;11(22):6565–6570. doi:10.7150/jca.49252
  • Nam SE, Lim W, Jeong J, et al. The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean breast cancer society registry. Breast Cancer Res Treat. 2019;177(3):669–678. doi:10.1007/s10549-019-05357-y
  • Jiao Z, Cao S, Jianhua L, et al. Clinical associations of preoperative and postoperative serum CEA and lung cancer outcome. Front Mol Biosci. 2021;8:686313. doi:10.3389/fmolb.2021.686313
  • Zayed AA, Beano AM, Amer FN, et al. Serum levels of carcinoembryonic antigen in patients with type 2 diabetes. Endocr Pract. 2016;22(11):1310–1318. doi:10.4158/EP161221.OR
  • Hasan M, Mohieldein A. Association between serum carcinoembryonic antigen level and oxidative stress parameters among diabetic females. Int J Clin Exp Med. 2015;8(4):6489–6494.
  • Choi SW, Benzie IF, Ma SW, et al. Acute hyperglycemia and oxidative stress: direct cause and effect? Free Radic Biol Med. 2008;44(7):1217–1231. doi:10.1016/j.freeradbiomed.2007.12.005
  • Weir GC, Butler PC, Bonner-Weir S. The β-cell glucose toxicity hypothesis: attractive but difficult to prove. Metabolism. 2021;124:154870. doi:10.1016/j.metabol.2021.154870